IP Library › Granted Patent US 9,434,700
Granted Patent B2
US 9,434,700 · App. 14/521,909 · Granted Sep 6, 2016

Inhibitors of the fibroblast growth factor receptor

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,434,700
App. No.
14/521,909
Granted
Sep 6, 2016
Kind
B2
Abstract

Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

Claims (4)

1. A compound or pharmaceutically acceptable salt thereof, wherein the compound is:

2. A pharmaceutical composition comprising the compound of claim 1 or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

3. A compound or pharmaceutically acceptable salt thereof, wherein the compound is:

4. A pharmaceutical composition comprising the compound of claim 3 or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

Assignments (4)
RELEASE OF SECURITY INTEREST (REEL/FRAME NUMBER 060616/0923) Recorded Jul 23, 2025
From: TAO TALENTS, LLC
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 072193/0847 →
SECURITY INTEREST Recorded Jul 8, 2022
From: BLUEPRINT MEDICINES CORPORATION
To: TAO TALENTS, LLC
Reel/Frame 060616/0923 →
ASSIGNEE CHANGE OF ADDRESS Recorded Jul 6, 2018
From: BLUEPRINT MEDICINES CORPORATION
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 046495/0375 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2016
From: BIFULCO, JR., NEIL, JR.; DIPIETRO, LUCIAN V.; HODOUS, BRIAN L.; MIDUTURU, CHANDRASEKHAR V.
To: BLUEPRINT MEDICINES CORPORATION
Reel/Frame 039145/0309 →